Mode
Text Size
Log in / Sign up

erythropoietin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of erythropoietin

6 trials tracked of erythropoietin: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 209 citations.

6Trials tracked
4Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 3 Phase 2 2
  1. Phase 3 High-dose Erythropoietin for Asphyxia and Encephalopathy Completed · 209 cited
  2. Phase 4 Nephropathy In Type 2 Diabetes and Cardio-renal Events Completed · 132 cited
  3. Phase 3 Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2) Completed
  4. Phase 3 Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes Completed
  5. Phase 2 Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS Completed
  6. Phase 2 Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.